Zhejiang Runtu Past Earnings Performance
Past criteria checks 0/6
Zhejiang Runtu's earnings have been declining at an average annual rate of -32.3%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been declining at an average rate of 1.6% per year. Zhejiang Runtu's return on equity is 0.6%, and it has net margins of 0.7%.
Key information
-32.3%
Earnings growth rate
-29.2%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | -1.6% |
Return on equity | 0.6% |
Net Margin | 0.7% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Zhejiang Runtu makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 5,496 | 38 | 440 | 222 |
31 Dec 23 | 5,588 | 46 | 470 | 222 |
30 Sep 23 | 5,614 | 158 | 463 | 217 |
30 Jun 23 | 5,765 | 251 | 464 | 216 |
31 Mar 23 | 6,031 | 405 | 492 | 218 |
31 Dec 22 | 6,268 | 607 | 497 | 246 |
30 Sep 22 | 6,187 | 717 | 486 | 252 |
30 Jun 22 | 6,237 | 935 | 506 | 278 |
31 Mar 22 | 5,736 | 870 | 494 | 281 |
01 Jan 22 | 5,572 | 836 | 502 | 250 |
30 Sep 21 | 5,825 | 900 | 527 | 260 |
30 Jun 21 | 5,718 | 814 | 522 | 252 |
31 Mar 21 | 5,502 | 734 | 542 | 213 |
31 Dec 20 | 5,228 | 788 | 526 | 197 |
30 Sep 20 | 5,059 | 849 | 649 | 188 |
30 Jun 20 | 5,510 | 918 | 609 | 184 |
31 Mar 20 | 5,855 | 1,340 | 627 | 209 |
31 Dec 19 | 6,513 | 1,370 | 650 | 231 |
30 Sep 19 | 6,521 | 1,374 | 617 | 215 |
30 Jun 19 | 6,322 | 1,434 | 641 | 232 |
31 Mar 19 | 6,671 | 1,267 | 666 | 236 |
31 Dec 18 | 6,464 | 1,313 | 637 | 234 |
30 Sep 18 | 6,613 | 1,311 | 601 | 254 |
30 Jun 18 | 6,536 | 1,239 | 459 | 339 |
31 Mar 18 | 6,199 | 1,081 | 475 | 278 |
31 Dec 17 | 6,057 | 935 | 480 | 234 |
30 Sep 17 | 5,795 | 860 | 483 | 164 |
30 Jun 17 | 5,189 | 798 | 631 | 0 |
31 Mar 17 | 4,896 | 762 | 575 | 0 |
31 Dec 16 | 4,353 | 660 | 545 | 0 |
30 Sep 16 | 4,172 | 495 | 560 | 0 |
30 Jun 16 | 4,181 | 398 | 508 | 0 |
31 Mar 16 | 4,104 | 457 | 526 | 0 |
31 Dec 15 | 4,522 | 734 | 542 | 0 |
30 Sep 15 | 4,805 | 1,079 | 570 | 0 |
30 Jun 15 | 4,870 | 1,220 | 553 | 0 |
31 Mar 15 | 5,234 | 1,290 | 630 | 0 |
31 Dec 14 | 5,345 | 1,287 | 610 | 0 |
30 Sep 14 | 5,390 | 1,223 | 552 | 0 |
30 Jun 14 | 5,555 | 1,235 | 592 | 0 |
31 Mar 14 | 5,295 | 1,052 | 514 | 0 |
31 Dec 13 | 4,801 | 824 | 501 | 0 |
30 Sep 13 | 4,243 | 575 | 502 | 0 |
30 Jun 13 | 3,884 | 421 | 472 | 0 |
Quality Earnings: 002440 has a large one-off loss of CN¥194.7M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 002440's current net profit margins (0.7%) are lower than last year (6.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002440's earnings have declined by 32.3% per year over the past 5 years.
Accelerating Growth: 002440's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002440 had negative earnings growth (-90.6%) over the past year, making it difficult to compare to the Chemicals industry average (-20.1%).
Return on Equity
High ROE: 002440's Return on Equity (0.6%) is considered low.